Abstract
CDC25 phosphatases control cell-cycle progression by dephosphorylating and activating cyclin-dependent kinases. CDC25B, one of the three members of this family in human cells, is thought to regulate initial mitotic events. CDC25B is an unstable protein whose proteasomal degradation is proposed to be controlled by β-TrCP. Here, we have investigated the regulation of CDC25B during mitosis, using time-lapse video microscopy. We found that CDC25B expression is high during early mitosis, and that its degradation occurs after the metaphase–anaphase transition and cyclin B1 destruction. We also show that CDC25B degradation after metaphase is dependent on the integrity of the KEN-box and RRKSE motifs that are located within the alternatively spliced B domain, and that the CDC25B2 splice variant, that lacks this domain, is stable during mitosis. Furthermore, we show that the N-terminal region of CDC25B, encompassing the B domain, undergoes major conformational changes during mitosis that can be monitored by intramolecular fluorescence resonance energy transfer variation of specific CDC25B biosensors. This study demonstrates that CDC25B splice variants have differential mitotic stabilities, a feature that is likely to have major consequences on the local control of cyclin-dependent kinase–cyclin activities during mitotic progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Baldin V, Cans C, Knibiehler M, Ducommun B . (1997a). Phosphorylation of human CDC25B phosphatase by CDK1/cyclin A triggers its proteasome-dependent degradation. J Biol Chem 272: 32731–32735.
Baldin V, Cans C, Superti-Furga G, Ducommun B . (1997b). Alternative splicing of the human CDC25B tyrosine phoshatase. Possible implications for growth control? Oncogene 14: 2485–2495.
Baldin V, Pelpel K, Cazales M, Cans C, Ducommun B . (2002). Nuclear localization of CDC25B1 and serine 146 integrity are required for induction of mitosis. J Biol Chem 277: 35176–35182.
Baldin V, Theis-Febvre N, Benne C, Froment C, Cazales M, Burlet-Schiltz O et al. (2003). PKB/Akt phosphorylates the CDC25B phosphatase and regulates its intracellular localisation. Biol Cell 95: 547–554.
Boutros R, Dozier C, Ducommun B . (2006). The when and where of CDC25 phosphatases. Curr Opin Cell Biol 18: 185–191.
Bugler B, Quaranta M, Aressy B, Brezak MC, Prevost G, Ducommun B . (2006). Genotoxic-activated G2–M checkpoint exit is dependent on CDC25B phosphatase expression. Mol Cancer Ther 5: 1446–1451.
Bulavin DV, Amundson SA, Fornace AJ . (2002). p38 and Chk1 kinases: different conductors for the G(2)/M checkpoint symphony. Curr Opin Genet Dev 12: 92–97.
Busino L, Donzelli M, Chiesa M, Guardavaccaro D, Ganoth D, Dorrello NV et al. (2003). Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage. Nature 426: 87–91.
Cans C, Ducommun B, Baldin V . (1999). Proteasome-dependent degradation of human CDC25B phosphatase. Mol Biol Reports 26: 53–57.
Cazales M, Schmitt E, Montembault E, Dozier C, Prigent C, Ducommun B . (2005). CDC25B phosphorylation by Aurora-A occurs at the G2/M transition and is inhibited by DNA damage. Cell Cycle 4: 1233–1238.
Chen F, Zhang Z, Bower J, Lu Y, Leonard SS, Ding M et al. (2002). Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin–proteasome pathway. Proc Natl Acad Sci USA 99: 1990–1995.
Clute P, Pines J . (1999). Temporal and spatial control of cyclin B1 destruction in metaphase. Nat Cell Biol 1: 82–87.
Davezac N, Baldin V, Gabrielli B, Forrest A, Theis-Febvre N, Yashida M et al. (2000). Regulation of CDC25B phosphatases subcellular localization. Oncogene 19: 2179–2185.
Donzelli M, Busino L, Chiesa M, Ganoth D, Hershko A, Draetta GF . (2004). Hierarchical order of phosphorylation events commits Cdc25A to betaTrCP-dependent degradation. Cell Cycle 3: 469–471.
Donzelli M, Squatrito M, Ganoth D, Hershko A, Pagano M, Draetta GF . (2002). Dual mode of degradation of Cdc25 A phosphatase. EMBO J 21: 4875–4884.
Dutertre S, Cazales M, Quaranta M, Froment C, Trabut V, Dozier C et al. (2004). Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2/M transition. J Cell Sci 117: 2523–2531.
Escalas N, Davezac N, De Rycke J, Baldin V, Mazars R, Ducommun B . (2000). Study of the cytolethal distending toxin-induced cell cycle arrest in HeLa cells: involvement of the CDC25 phosphatase. Exp Cell Res 257: 206–212.
Forrest AR, McCormack AK, DeSouza CP, Sinnamon JM, Tonks ID, Hayward NK et al. (1999). Multiple splicing variants of cdc25B regulate G2/M progression. Biochem Biophys Res Commun 260: 510–515.
Gabrielli BG, De Souza CPC, Tonks ID, Clarck JM, Hatward NK, Ellem KAO . (1996). Cytoplasmic accumulation of CDC25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. J Cell Sci 109: 1081–1093.
Hernandez S, Bessa X, Bea S, Hernandez L, Nadal A, Mallofre C et al. (2001). Differential expression of cdc25 cell-cycle-activating phosphatases in human colorectal carcinoma. Lab Invest 81: 465–473.
Hernandez S, Hernandez L, Bea S, Pinyol M, Nayach I, Bellosillo B et al. (2000). cdc25a and the splicing variant cdc25b2, but not cdc25B1, -B3 or -C, are over-expressed in aggressive human non-Hodgkin's lymphomas. Int J Cancer 89: 148–152.
Jin J, Shirogane T, Xu L, Nalepa G, Qin J, Elledge SJ et al. (2003). SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev 17: 3062–3074.
Kanemori Y, Uto K, Sagata N . (2005). TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases. Proc Natl Acad Sci USA 102: 6279–6284.
Karlsson C, Katich S, Hagting A, Hoffmann I, Pines J . (1999). Cdc25B and Cdc25C differ markedly in their properties as initiators of mitosis. J Cell Biol 146: 573–584.
Korner K, Jerome V, Schmidt T, Muller R . (2001). Cell cycle regulation of the murine cdc25B promoter: essential role for nuclear factor-Y and a proximal repressor element. J Biol Chem 276: 9662–9669.
Kristjansdottir K, Rudolph J . (2004). Cdc25 phosphatases and cancer. Chem Biol 11: 1043–1051.
Lemaire M, Froment C, Boutros R, Mondesert O, Nebreda AR, Monsarrat B et al. (2006). CDC25B phosphorylation by p38 and MK-2. Cell Cycle 5: 1649–1653.
Lindqvist A, Kallstrom H, Karlsson Rosenthal C . (2004). Characterisation of Cdc25B localisation and nuclear export during the cell cycle and in response to stress. J Cell Sci 117: 4979–4990.
Lindqvist A, Kallstrom H, Lundgren A, Barsoum E, Rosenthal CK . (2005). Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosome. J Cell Biol 171: 35–45.
Manke IA, Nguyen A, Lim D, Stewart MQ, Elia AE, Yaffe MB . (2005). MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol Cell 17: 37–48.
Mirey G, Chartrain I, Froment C, Quaranta M, Bouche JP, Monsarrat B et al. (2005). CDC25B phosphorylated by pEg3 localizes to the centrosome and the spindle poles at mitosis. Cell Cycle 4: 806–811.
Miyata H, Doki Y, Yamamoto H, Kishi K, Takemoto H, Fujiwara Y et al. (2001). Overexpression of CDC25B overrides radiation-induced G2–M arrest and results in increased apoptosis in esophageal cancer cells. Cancer Res 61: 3188–3193.
Miyawaki A, Tsien RY . (2000). Monitoring protein conformations and interactions by fluorescence resonance energy transfer between mutants of green fluorescent protein. Methods Enzymol 327: 472–500.
Morgan DO . (1995). Principles of CDK regulation. Nature 374: 131–134.
Nishijima H, Nishitani H, Seki T, Nishimoto T . (1997). A dual-specificity phosphatase Cdc25B is an unstable protein and triggers p34(cdc2)/cyclin B activation in hamster BHK21 cells arrested with hydroxyurea. J Cell Biol 138: 1105–1116.
Pfleger CM, Kirschner MW . (2000). The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1. Genes Dev 14: 655–665.
Schmitt E, Boutros R, Froment C, Monsarrat B, Ducommun B, Dozier C . (2006). CHK1 phosphorylates CDC25B during the cell cycle in the absence of DNA damage. J Cell Sci 119: 4265–4275.
Theis-Febvre N, Filhol O, Froment C, Cazales M, Cochet C, Monsarrat B et al. (2003). Protein kinase CK2 regulates CDC25B phosphatase activity. Oncogene 22: 220–232.
van Vugt MA, Bras A, Medema RH . (2004). Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol Cell 15: 799–811.
van Vugt MA, Medema RH . (2005). Getting in and out of mitosis with Polo-like kinase-1. Oncogene 24: 2844–2859.
Acknowledgements
We gratefully acknowledge Rose Boutros for comments and suggestions on the manuscript, Martine Cazales and Christine Didier for help and technical support. We thank R Tsien, W Earnshaw and D Piston for plasmids and reagents. This work was supported by the CNRS, l'Université Paul Sabatier and la Ligue Nationale Contre le Cancer to BD (Equipe labellisée 2005).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Rights and permissions
About this article
Cite this article
Kieffer, I., Lorenzo, C., Dozier, C. et al. Differential mitotic degradation of the CDC25B phosphatase variants. Oncogene 26, 7847–7858 (2007). https://doi.org/10.1038/sj.onc.1210596
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210596
Keywords
This article is cited by
-
Revealing β-TrCP activity dynamics in live cells with a genetically encoded biosensor
Nature Communications (2022)
-
LSD1 is essential for oocyte meiotic progression by regulating CDC25B expression in mice
Nature Communications (2015)
-
Overexpression of mutant cell division cycle 25 homolog B (CDC25B) enhances the efficiency of selection in Chinese hamster ovary cells
Cytotechnology (2013)
-
Unscheduled expression of CDC25B in S-phase leads to replicative stress and DNA damage
Molecular Cancer (2010)
-
CDC25 phosphatases in cancer cells: key players? Good targets?
Nature Reviews Cancer (2007)